Mark, thank you. And thanks to all of those who are listening in on today's call this afternoon .Before we talk about our second quarter, let me update everyone on how Covid-19 pandemic has affected our business. In early March, we started to take measures at our company to help secure the health of our employees and vendors. When the stay at home order in North Carolina was implemented, we temporarily closed our corporate office, instituted remote workforce and altered work schedules at our manufacturing and warehouse facilities. We also took steps to increase production to build up our finished goods inventory, as well as purchase additional raw material inventory items thereby allowing us to maintain production, if supply chain interruptions were to happen which at this point I'm happy to say has not happened. In short, while we have had to make significant logistical changes during the past 60 days, our team has risen to the challenge and our business has remained fully open and operational. We are happy to report that as of today we are not aware of any of our employees who have tested positive Covid-19. Along with taking the necessary safety measures, we also immediately instituted a rigorous cost containment plan across all departments and shifted resources from our B2B retail brick-and-mortar sales to our direct-to-consumer online sales. The result has been quite remarkable. While we normally don't discuss results to mid-quarter, we are in an unprecedented time and therefore I've decided to talk about what our company's operations now look like in April, our first full post Covid impacted month. First of all, our overall sales in April were in line with monthly sales from our March ending quarter, effectively meaning our sales have not gone down. Second, we are seeing a significant shift in our overall sales blend where now our direct-to-consumer online sales are tracking at 80%, up from 62% of overall sales in fiscal 2019. This of course has helped us maintain a very healthy overall gross profit margin, which we believe we can maintain at 65% or higher going forward. Third and most dramatic, our overall operating expenses have been reduced approximately 40% in April from our monthly average in the prior quarter. Some of this operational cost reduction is the direct result of cancellation of certain spends, but others such as travel and trade shows, our direct effect from the changing environment brought on by Covid-19 pandemic. The net result of all these changes is that in April, we are showing an approximate 85% decrease in our loss from operations from just a few months ago. And we are also seeing as carry through as we cross the midway point in May. While the uncertainty caused by the pandemic requires us to withdraw our fiscal 2020 financial guidance based on what we are experiencing, we remain confident that we will achieve our target of a positive cash flow by the end of 2020 and perhaps sooner. In addition with approximately $14.8 million in cash on hand at March 31st, 2020 and the dramatic improvement in our overall operating results, we believe we have more than enough financial cushion to get us to profitability absent of any unforeseen impact from Covid-19. Despite these truly horrific times, we are thankful that earlier this year we made bold, strategic decisions such as becoming fully capitalized in January of 2020, paying for infrastructure so we have almost no debt, maintaining and strengthening our online direct-to-consumer business model, which had allowed us to pivot when needed and choosing to operate our business with a view towards variable cost initiatives instead of like many of our competitors who are locked in long-term arrangements are now drowning in debt and have no way to generate sales because they embarked on a bed at all big-box retailer strategy. I am on the record last year saying, I believe 2020 was a year that the CBD industry would see an industry-wide shakeout. I said that hundreds of smaller brands who jumped into space would simply not be able to survive competition and regulation. Now the Covid-19 pandemic is upon us, this shake out in the CBD industry is now magnified in its intensity. When we enter the public market as a pure-play CBD company in December of 2018, our sales were a fraction of the leaders. Now in less than 18-months, we are not only one of the biggest CBD companies in America, but we also have two of the most recognizable CBD brands in America. With that said I'm pleased to announce the cbdMD reported $9.4 million in quarterly net sales for the second quarter of fiscal 2020. This is a 67% increase over the same quarter last year. And our gross profit margins remain strong at 67% year-to-date. Our overall direct-to-consumer e-commerce sales for the March fiscal quarter was $6.8 million or 72% of our total net sales, an increase of $2.5 million or 58% from the prior year's quarter. Our B2B brick-and-mortar sales were $2.6 million or 28% of our total net sales, an increase of $1.2 million or 85% from the prior year's quarters. Direct-to-consumer e-commerce sales for the six months ending March were $13.6 million or 70% of our total net sales, an increase of $8.9 million or 189% from the prior year period. Our B2B brick-and-mortar sales were $5.9 million or 30% of total net sales, an increase of $4.5 million or 321% from the prior year period. As previously discussed, we completed an $18.9 million equity offering in January and a few weeks ago we received a $1.5 million loan from the Paycheck Protection Program which could be forgiven based on future criteria being met, coupled together and with a significant reduction in operating burn, we are confident we are fully financed to operate the profitability again with a significant cash cushion. We will continue to drive online sales to the use of various digital marketing programs. Currently, we have over 250,000 active e-commerce subscribers, a number that continues to grow every month. On the B2B brick-and-mortar side of our business, we continue to grow the amount of retail stores who currently carry our brands. We are pleased to announce that our retail reach is now over 6,300 retail doors, an increase of over 1,000 doors since last quarter and we continue to see an increase in our international sales as we are now currently selling to wholesale customers in 16 international markets. While the Covid-19 pandemic has affected our overall B2B brick-and-mortar distribution channels, we are hopeful that during next to 12 to 18 months, a vaccine will be discovered at which point we believe that B2B brick-and-mortar will quickly return to pre Covid levels. During calendar 2019, we invested heavily in brand development, acquiring brand building assets as well as our physical infrastructure with the build-out of our 40,000 square foot full-scale manufacturing facility. Our 80,000 square foot logistics warehouse and distribution center and our 50,000 square foot headquarters. We continue to invest in R&D and testing to ensure the highest safety and quality for all of our products. Our commitment to quality was recently rewarded as we were honored in February that two of the best selling products, our CBD PM Sleep Aid and our cbdMD Free Topical voted the winner of the prestigious 2020 Product of the Year award in the Sleep Aid and CBD topical categories respectively. This is America's largest consumer voted award for product innovation as 40,000 voters participated in an online study organized by independent research firm Kantar Media Group. We are also pleased to announce in March that we added to NSF International Dietary Supplements good manufacturing process GMP registration. We entered 2020 with a significant tailwind in product and brand development where our accolades saw the prestigious industry-leading predictive analytics and market research firm for the CBD industry, the bright field group named cbdMD a Top 10 domestic brand in two booming categories, topical and skincare and beauty. And in November 2018, cbdMD was ranked the highest in terms of overall consumer satisfaction, as well as the highest in unaided consumer awareness of any of the Top 10 CBD brands in a survey conducted by Brightfield Group of more than 3,500 cbdMD users. Paw CBD, our dynamic pet product offering which consists of a comprehensive line of CBD pet products for dogs, cats and horses was also ranked by Brightfield as one of the Top 5 brands in the animal CBD market. These achievements solidify that our cbdMD and Paw CBD brands now sit atop the CBD industry as two of the most trusted CBD brands in the market today. This brand building success has also presented us with new exciting opportunities such as our recently announced plan start a joint venture with holistic pet foods leader Halo, a premium natural pet food brand with a rich 30-year operating history for the long-standing distribution channels in many large big-box retailers such as Petsmart and Petco. Paw CBD is currently sold by independent pet store channels and online at pawscbd.com. Our goal is for paws CBD to be in over a 1,000 retail stores grooming salons and veterinary clinics this year. Our sponsorship and influencer partnerships are first in class in the CBD industry and include such multibillion dollar partners such as Lifetime Fitness and Bellator MMA, a wholly owned subsidiary of Viacom. We are pleased to announce that our agreement with Lifetime where cbdMD is the exclusive CBD partner of Lifetime is expanding to include the sales of CBD products throughout both Lifetime e-commerce and retail in club channels, with approximately 2 million active members, Lifetime provides an incredible opportunity to directly offer a robust line of THC free CBD products to this targeted base of consumers who are laser focused on the importance of health and well-being each and every day. We feel confident that if our products are introduced online through their shop Lifetime website and in their 145 plus fitness facilities nationwide sales will be significant. One indication of the potential demand among their membership is that research provided to us by Lifetime indicated that cbdMD was the number one search term on the Lifetime e-commerce website since our partnership began in October 2019. We are excited to get our products in Lifetime spas and cafes as well as in the hands of all their nutritionists and fitness coaches serving their 2 million members. cbdMD our commitment to health and wellness represents a perfect fit with Lifetime since our roster of team cbdMD athletes includes some of the biggest and most notable individuals in their respective sports. Our products are THC free and like Lifetime cbdMD is a leading trusted brand which is consumer purchase data regarding CBD suggests is a dominant factor in decision making. Finally, with respect to the regulatory climate for CBD, prior to Covid-19, it was our expectation that the FDA would announce regulatory guidance for CBD in the first half of 2021. Now that the government is fast tracking business in America in an effort to restart our economy, we would hope that the FDA would release its CBD guidance sooner hopefully by the end of 2020 possibly by enacting legislation like HR5587 which is currently working its way through the House of Representatives. Now let me turn the call over to Mark to review our most recent financial results.